A detailed history of Macquarie Group LTD transactions in Xoma Corp stock. As of the latest transaction made, Macquarie Group LTD holds 3,466 shares of XOMA stock, worth $90,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,466
Previous 3,466 -0.0%
Holding current value
$90,116
Previous $83,000 1.2%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020

SELL
$18.45 - $25.51 $36,420 - $50,356
-1,974 Reduced 36.29%
3,466 $68,000
Q1 2020

May 15, 2020

BUY
$15.11 - $28.71 $29,827 - $56,673
1,974 Added 56.95%
5,440 $111,000
Q4 2019

Feb 14, 2020

SELL
$17.5 - $28.66 $844,742 - $1.38 Million
-48,271 Reduced 93.3%
3,466 $95,000
Q3 2019

Nov 14, 2019

SELL
$15.02 - $21.51 $22,184 - $31,770
-1,477 Reduced 2.78%
51,737 $1.01 Million
Q2 2019

Nov 06, 2019

BUY
$11.83 - $18.98 $612,048 - $981,968
51,737 Added 3502.84%
53,214 $791,000
Q2 2019

Aug 14, 2019

SELL
$11.83 - $18.98 $594,575 - $953,934
-50,260 Reduced 97.15%
1,477 $22,000
Q1 2019

May 15, 2019

SELL
$11.95 - $15.53 $30,890 - $40,145
-2,585 Reduced 4.76%
51,737 $641,000
Q4 2018

Feb 15, 2019

BUY
$11.27 - $17.54 $28,310 - $44,060
2,512 Added 4.85%
54,322 $687,000
Q3 2018

Nov 15, 2018

SELL
$15.67 - $25.73 $261,689 - $429,691
-16,700 Reduced 24.38%
51,810 $910,000
Q2 2018

Aug 14, 2018

SELL
$19.68 - $25.28 $98,400 - $126,400
-5,000 Reduced 6.8%
68,510 $1.43 Million
Q1 2018

May 11, 2018

BUY
$19.86 - $35.92 $401,370 - $725,943
20,210 Added 37.92%
73,510 $1.49 Million
Q4 2017

Feb 15, 2018

BUY
$19.71 - $36.79 $262,143 - $489,307
13,300 Added 33.25%
53,300 $1.9 Million
Q3 2017

Nov 08, 2017

BUY
$7.31 - $20.8 $292,400 - $832,000
40,000
40,000 $786,000

Others Institutions Holding XOMA

About XOMA Corp


  • Ticker XOMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,450,800
  • Market Cap $298M
  • Description
  • XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...
More about XOMA
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.